Take Solutions is currently trading at Rs 138.65, up by 1.05 points or 0.76% from its previous closing of Rs. 137.60 on the BSE.
The scrip opened at Rs. 138.60 and has touched a high and low of Rs. 140.75 and Rs. 137.20 respectively. So far 55071 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 210.50 on 02-Dec-2015 and a 52 week low of Rs. 87.10 on 07-May-2015.
Last one week high and low of the scrip stood at Rs. 140.80 and Rs. 133.00 respectively. The current market cap of the company is Rs. 1694.63 crore.
The promoters holding in the company stood at 68.72% while Institutions and Non-Institutions held 6.47% and 24.80% respectively.
TAKE Solutions has achieved its landmark 100th customer win for pharmaREADY, its fully integrated, regulatory compliant, web-based product suite. This flagship product suite was launched in the market in 2005, evolving over the years through 10 major update releases, and now caters to 100 global customers across North America, Europe, Middle East, Australia, China & India. pharmaREADY clients include Microlabs, Aurobindo Pharma, Piramal Enterprise, Intas Pharma, Macleods Pharma and Manipal College of Pharmaceutical Sciences (MCOPS).
pharmaREADY is a cloud or on premise regulatory suite comprised of Document Management, Training Records Management, Structured Product Labelling and Electronic Common Technical Document (eCTD) Publishing Solutions. The solution simplifies the complex process of creating, viewing, and managing drug approval submissions to Health Authorities like US-FDA, Health Canada, European Medicines Authority, Swiss Medic, Saudi FDA, Australia and South Africa.
Take Solutions is a globally recognized knowledge intensive technology player, delivering comprehensive and niche solutions for enterprises across diverse sectors for over 15 years, with key expertise in Life Sciences (LS) and Supply Chain Management (SCM).
| Company Name | CMP |
|---|---|
| TCS | 4248.55 |
| Infosys | 1949.80 |
| HCL Tech. | 1825.90 |
| Wipro | 292.55 |
| Tech Mahindra | 1675.95 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
